Galenvs is a specialized precision developer & manufacturer of nanomaterials and DNA/RNA oligonucleotides for therapeutics and diagnostic applications, offering services from proof-of-concept through in-vitro validation and pilot-scale production.
Why choose us?
- Proven track record of delivering solutions for a variety of industries from human to environmental and animal health
- Vertical integration from lead optimization, synthesis, purification, validation and pilot-scale production
- Rapid turnaround from proof-of-concept to pilot-scale informed by rich data set and predictive models
Our proprietary multidisciplinary technologies in functional nanomaterials and oligonucleotide synthesis deliver value for our healthcare and industry partners. We excel in tackling complex challenges and designing robust, tailored processes optimized for client product requirements.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 6750 Rue Hutchison, Suite 201,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://galenvs.com
- Keywords
- biochemistry, machine learning, research, biomedical, biotechnology, oligonucleotides, DNA, RNA, Nanopaticles, magnetic nanoparticles, purification, detection, therapeutics, diagnostics, biomanufacturing, RNA therapeutics.
- HQ
- Montreal, Quebec
Galenvs Sciences Questions
Galenvs Sciences's website is http://galenvs.com
Galenvs Sciences's LinkedIn profile is https://ca.linkedin.com/company/galenvs
Galenvs Sciences has
14 employees.
View email and phone details for 14
employees at Galenvs Sciences.
Galenvs Sciences's industry is
Biotechnology Research
Galenvs Sciences's top competitors are
Cxc,
Nomic Bio,
Proventus Bioscience,
Biovectra,
Amspec Group,
Entos Pharmaceuticals,
Chem Science Inc,
Northern Rna Inc.,
Iwa-Ywp Canada,
Cqdm.
Galenvs Sciences's categories are Biotechnology Research
Galenvs Sciences's founding year is 2019
